Contact

“I am delighted that my 45 years’ preclinical and clinical research have reached this significant milestone. There is a great medical need for new treatments to address initiation of labor and I hope that tafoxiparin will make a difference for all these pregnant women.”

Professor Gunvor Ekman Ordeberg, Founder and CMO